Company intelligence / Profile preview

FIR Capital Partners

Belo Horizonte, Minas Gerais, Brazil

Ownership: Private
Development stage: Other

Overview

FIR Capital is a prominent Brazilian venture capital and private equity firm focused on high-impact investments in the technology and life sciences sectors. Established in 2002 and based in Belo Horizonte, the firm is a pioneer in the Brazilian innovation ecosystem, notably managing the Fundo de Inovação em Biotecnologia (FIB). FIR Capital provides strategic support and capital to companies at various stages of growth, with a portfolio that includes significant Brazilian biotechnology firms such as Biomm and Recepta Biopharma. As a member of the DFJ Global Network, the firm leverages international expertise and connections to scale its portfolio companies globally.

Industry: Investors

Partnerships

Draper Fisher Jurvetson

Beyond the preview

Go deeper on FIR Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FIR Capital Partners.

Explore the full profile